NCT04770272 2026-01-12
neoMono
Palleos Healthcare GmbH
Phase 2 Terminated
Clinical Trials
3 trialsNCT07016399 2025-10-30
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
NCT01009437 2017-12-05
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed